| Todd Bell, MD | |
|
1400 S Coulter, Amarillo, TX 79106-1786 | |
| (806) 354-5660 | |
| (806) 354-5717 |
| Full Name | Todd Bell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 1400 S Coulter, Amarillo, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093747156 | NPI | - | NPPES |
| 178239303 | Medicaid | TX | |
| 178239304 | Medicaid | TX | |
| 178239305 | Medicaid | TX | |
| 48030244 | Medicaid | NM | |
| 200074040A | Medicaid | OK | |
| 178239301 | Medicaid | TX | |
| 178239302 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | M2560 (Texas) | Secondary |
| 207R00000X | Internal Medicine | M2560 (Texas) | Secondary |
| 208000000X | Pediatrics | M2560 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Tech University Health Sciences Center Amarillo | 9234037847 | 71 |
News Archive
BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Phase I clinical studies in 2010.
Making workplaces smoke-free would prevent an estimated 610 stroke and heart attack deaths in the first year alone, mostly among non-smokers. Over seven years, the study projects that more than 2,420 lives and $280 million would be saved – not including the costs associated with other smoking-related illnesses or lost productivity.
An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market.
NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.
› Verified 9 days ago
| Entity Name | Texas Tech University Health Sciences Center Amarillo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013942150 PECOS PAC ID: 9234037847 Enrollment ID: O20031220000051 |
News Archive
BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Phase I clinical studies in 2010.
Making workplaces smoke-free would prevent an estimated 610 stroke and heart attack deaths in the first year alone, mostly among non-smokers. Over seven years, the study projects that more than 2,420 lives and $280 million would be saved – not including the costs associated with other smoking-related illnesses or lost productivity.
An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market.
NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.
› Verified 9 days ago
| Entity Name | Texas Tech University Health Sciences Center Amarillo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871525840 PECOS PAC ID: 9234037847 Enrollment ID: O20041124000080 |
News Archive
BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Phase I clinical studies in 2010.
Making workplaces smoke-free would prevent an estimated 610 stroke and heart attack deaths in the first year alone, mostly among non-smokers. Over seven years, the study projects that more than 2,420 lives and $280 million would be saved – not including the costs associated with other smoking-related illnesses or lost productivity.
An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market.
NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Todd Bell, MD 1400 Wallace Blvd, Attn: Credentialing, Amarillo, TX 79106-1708 Ph: (806) 354-5585 | Todd Bell, MD 1400 S Coulter, Amarillo, TX 79106-1786 Ph: (806) 354-5660 |
News Archive
BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Phase I clinical studies in 2010.
Making workplaces smoke-free would prevent an estimated 610 stroke and heart attack deaths in the first year alone, mostly among non-smokers. Over seven years, the study projects that more than 2,420 lives and $280 million would be saved – not including the costs associated with other smoking-related illnesses or lost productivity.
An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market.
NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.
› Verified 9 days ago
Mrs. Cynthia Milagros Correa-colon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 | |
Dr. Kinsley Ann Stepka, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St Ste 1500, Amarillo, TX 79106 Phone: 806-414-9800 | |
Muhammad Asif Qureshi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-354-5630 Fax: 806-354-5568 | |
Shu Shum, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1801 Halstead St, Amarillo, TX 79106 Phone: 806-358-8526 Fax: 806-358-0179 | |
Robin Elaine Martinez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6305 Sunlake Dr, Amarillo, TX 79124 Phone: 806-352-1020 | |
Jason Nirgiotis, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9800 Fax: 806-354-5689 | |
Dr. Debbie Pamela Hoving, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1901 Medi Park Dr Ste 200, Amarillo, TX 79106 Phone: 806-468-4350 Fax: 806-468-4351 |